Inyx Pharma

Inyx was a specialty pharmaceutical company and contract manufacturing organization (CMO) that focused on the development and production of aerosol and respiratory drug delivery systems. The company specialized in metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nasal sprays, serving both as a developer of its own generic products and as a partner for major pharmaceutical firms. At its peak, Inyx operated significant manufacturing facilities in the United Kingdom and the United States. However, the company faced severe financial distress and legal challenges, leading to its insolvency and the sale of its primary assets in the late 2000s.